December was the second-worst month on record
To be managed by Charles Luke and Thomas Moore
Fifteen new indices
Latest accounts show profits fell to £16.2m to 31 March 2019
Follows November Cayman launch
Follows strong year for inflows
Focus on medical cannabis
Fund 'remains viable and fully invested'
Not focusing on valuation key to 'winning in the stockmarket'
Allianz China A-shares tops charts
Following December suspension
Will require an industry-wide 'change in attitude'
Plan to launch ESG ETFs
The biggest headlines from 2019
The stocks to remember – and the ones to forget
Seeking early-stage assets
All-time high £6.9bn raised
Operational resilience and liquidity under scrutiny
Tim Crockford to head team
May also impact the provision of finance to the economy
Group will rethink retail exposure